Covid-19：ケニアがアビガン治療薬を検討：Director of Health Patrick Amoth：
Covid-19: Kenya to use Japanese flu drug for treatment：
Covid-19：肯尼亚将使用日本流感药物进行治疗
Covid-19：ケニア
ケニアも、抗ウイルス治療薬アビガンの供与を受けるために、日本と協議中です。
MAGDALINE SAYA：ニュース
ケニアは、インフルエンザ治療薬アビガンを、新型コロナウイルス治療に使う予定。
ケニア保健部長代理：パトリック・アモス
先月、中国ではCovid-19の実験的治療薬として、アビガンが使われました。
私たちは非常に有望な抗ウイルス剤を開発した日本政府と協議中です。
アモス氏は昨日、記者団に対し、｢日本と中国での治験実績結果の発表に、期待している｣と語りました。
Covid-19: Kenya to use Japanese flu drug for treatment
In Summary
Kenya is in discussion with Japan to receive batches of the antiviral drug, called Favipiravir or Avigan.
Favipiravir was originally developed to treat influenza by Toyama Chemical
by MAGDALINE SAYA News
Acting Director of Health Patrick Amoth
said the government was in discussion with Japan to receive batches of the antiviral drug, called Favipiravir or Avigan.
The drug has been used for years in Japan to treat influenza and, last month, it was approved as an experimental treatment for Covid-19.
We are in discussion with the government of Japan who have developed an antiviral which has shown very good promise,
so that we can get some doses that our physicians can also be able to try for Covid-19.
And we are hopeful that we will also tell our results like what they have done in Japan and China,Amoth told journalists yesterday.